Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0BU6K
|
|||
Drug Name |
Aryl piperazine derivative 9
|
|||
Synonyms |
PMID26609882-Compound-47
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
ARENA PHARMACEUTICALS, INC
|
|||
Structure |
Download2D MOL |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | 5-HT 2A receptor (HTR2A) | Target Info | Agonist | [1] |
5-HT 2C receptor (HTR2C) | Target Info | Agonist | [1] | |
Target's Patent Info | 5-HT 2A receptor (HTR2A) | Target's Patent Info | [1] | |
5-HT 2C receptor (HTR2C) | Target's Patent Info | [1] | ||
KEGG Pathway | Calcium signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
Gap junction | ||||
Serotonergic synapse | ||||
Inflammatory mediator regulation of TRP channels | ||||
Panther Pathway | 5HT2 type receptor mediated signaling pathway | |||
Reactome | Serotonin receptors | |||
G alpha (q) signalling events | ||||
WikiPathways | Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||
Monoamine GPCRs | ||||
GPCRs, Class A Rhodopsin-like | ||||
Gastrin-CREB signalling pathway via PKC and MAPK | ||||
GPCR ligand binding | ||||
GPCR downstream signaling | ||||
Serotonin Receptor 2 and STAT3 Signaling | ||||
SIDS Susceptibility Pathways | ||||
GPCRs, Other |
References | Top | |||
---|---|---|---|---|
REF 1 | Novel serotonin receptor 2 (5-HT2R) agonists and antagonists: a patent review (2004-2014).Expert Opin Ther Pat. 2016;26(1):89-106. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.